HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5167.53M
Enterprise Value 3224.47M
Trailing P/E N/A
Forward P/E 117.62
PEG Ratio (5 yr expected) 12.15
Price/Sales (ttm)1.36
Price/Book (mrq)2.16
Enterprise Value/Revenue 31.82
Enterprise Value/EBITDA 627.78

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin -4.02%
Operating Margin (ttm)2.09%

Management Effectiveness

Return on Assets (ttm)1.17%
Return on Equity (ttm)-9.00%

Income Statement

Revenue (ttm)123.12M
Revenue Per Share (ttm)3.49
Quarterly Revenue Growth (yoy)66.30%
Gross Profit (ttm)47.6M
Net Income Avi to Common (ttm)-6.85M
Diluted EPS (ttm)-0.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.62M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)61.47M
Total Debt/Equity (mrq)79.81
Current Ratio (mrq)2.42
Book Value Per Share (mrq)2.12

Cash Flow Statement

Operating Cash Flow (ttm)2.92M
Levered Free Cash Flow (ttm)11.45M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.74
52-Week Change 324.59%
S&P500 52-Week Change 38.19%
52 Week High 36.70
52 Week Low 32.95
50-Day Moving Average 35.28
200-Day Moving Average 35.32

Share Statistics

Avg Vol (3 month) 3235.07k
Avg Vol (10 day) 3140.38k
Shares Outstanding 536.58M
Float 32.01M
% Held by Insiders 112.84%
% Held by Institutions 175.89%
Shares Short (Sep 28, 2018) 41.42M
Short Ratio (Sep 28, 2018) 49.48
Short % of Float (Sep 28, 2018) 44.74%
Short % of Shares Outstanding (Sep 28, 2018) 43.87%
Shares Short (prior month Aug 31, 2018) 41.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21319/1000
Last Split Date 3Nov 4, 2013